Mohedas, A., Wang, Y., Sanvitale, C., Canning, P., Choi, S., Xing, X., . . . Yu, P. (2014). Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.
Style de citation Chicago (17e éd.)Mohedas, A., Y. Wang, C. Sanvitale, P. Canning, S. Choi, X. Xing, A. Bullock, G. Cuny, et P. Yu. Structure-activity Relationship of 3,5-diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants. 2014.
Style de citation MLA (9e éd.)Mohedas, A., et al. Structure-activity Relationship of 3,5-diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants. 2014.